{"entity":{"type":"insider","cik":"0001732091","url":"/insider/0001732091","json_url":"/insider/0001732091.json","name":"Girshick Birgit","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":159,"n_filings":17,"first":"2018-03-07","last":"2026-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Girshick Birgit","source":"filing","n_filings":17,"first_seen":"2018-03-07","last_seen":"2026-08-13"}],"transactions":[{"id":9221464,"accession":"0001100682-26-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001100682-26-000132","line_url":"/filing/0001100682-26-000132#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":279.9,"price_display":"279.90","price_state":"stated","total_value":1819350.0,"total_display":"1,819,350.00","total_whole":"1,819,350","shares_owned_after":36013.0,"shares_owned_after_display":"36,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-13","scope":"insider"},{"id":5131086,"accession":"0001127602-25-006251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-006251","line_url":"/filing/0001127602-25-006251#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP & COO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1514.0,"shares_display":"1,514","price_per_share":164.63,"price_display":"164.63","price_state":"stated","total_value":249249.82,"total_display":"249,249.82","total_whole":"249,250","shares_owned_after":55058.0,"shares_owned_after_display":"55,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-21","scope":"insider"},{"id":8571121,"accession":"0001127602-23-028148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-028148","line_url":"/filing/0001127602-23-028148#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP & COO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1322.0,"shares_display":"1,322","price_per_share":187.82,"price_display":"187.82","price_state":"stated","total_value":248298.04,"total_display":"248,298.04","total_whole":"248,298","shares_owned_after":44449.0,"shares_owned_after_display":"44,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":7892676,"accession":"0001127602-23-005905","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001127602-23-005905","line_url":"/filing/0001127602-23-005905","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP & COO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3205.0,"shares_display":"3,205","price_per_share":254.3867783775351,"price_display":"254.39","price_state":"stated","total_value":815309.6247,"total_display":"815,309.62","total_whole":"815,310","shares_owned_after":41540.0,"shares_owned_after_display":"41,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider","n_lines":10},{"id":4317065,"accession":"0001127602-21-025281","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-025281","line_url":"/filing/0001127602-21-025281#line-4","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2344.0,"shares_display":"2,344","price_per_share":439.9,"price_display":"439.90","price_state":"stated","total_value":1031125.6,"total_display":"1,031,125.60","total_whole":"1,031,126","shares_owned_after":27602.0,"shares_owned_after_display":"27,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider"},{"id":4317060,"accession":"0001127602-21-025281","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-025281","line_url":"/filing/0001127602-21-025281","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81.0,"shares_display":"81","price_per_share":442.1879012345679,"price_display":"442.19","price_state":"stated","total_value":35817.22,"total_display":"35,817.22","total_whole":"35,817","shares_owned_after":29953.0,"shares_owned_after_display":"29,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider","n_lines":3},{"id":4886336,"accession":"0001127602-21-013373","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-21-013373","line_url":"/filing/0001127602-21-013373","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18311.0,"shares_display":"18,311","price_per_share":302.61068483425265,"price_display":"302.61","price_state":"stated","total_value":5541104.25,"total_display":"5,541,104.25","total_whole":"5,541,104","shares_owned_after":29060.0,"shares_owned_after_display":"29,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-06","filed_date":"2021-04-07","scope":"insider","n_lines":3},{"id":4886291,"accession":"0001127602-21-013373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-013373","line_url":"/filing/0001127602-21-013373#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":999.0,"shares_display":"999","price_per_share":298.0,"price_display":"298.00","price_state":"stated","total_value":297702.0,"total_display":"297,702.00","total_whole":"297,702","shares_owned_after":29060.0,"shares_owned_after_display":"29,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider"},{"id":5208190,"accession":"0001127602-21-007209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-007209","line_url":"/filing/0001127602-21-007209#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1675.0,"shares_display":"1,675","price_per_share":293.9168,"price_display":"293.92","price_state":"stated","total_value":492310.64,"total_display":"492,310.64","total_whole":"492,311","shares_owned_after":30005.0,"shares_owned_after_display":"30,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":2108603,"accession":"0001127602-20-024018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-024018","line_url":"/filing/0001127602-20-024018#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":933.0,"shares_display":"933","price_per_share":213.51,"price_display":"213.51","price_state":"stated","total_value":199204.83,"total_display":"199,204.83","total_whole":"199,205","shares_owned_after":22852.0,"shares_owned_after_display":"22,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-21","scope":"insider"},{"id":2970924,"accession":"0001127602-20-016332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-016332","line_url":"/filing/0001127602-20-016332#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":780.0,"shares_display":"780","price_per_share":165.74,"price_display":"165.74","price_state":"stated","total_value":129277.2,"total_display":"129,277.20","total_whole":"129,277","shares_owned_after":21837.0,"shares_owned_after_display":"21,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider"},{"id":2256869,"accession":"0001127602-20-005411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-005411","line_url":"/filing/0001127602-20-005411#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":172.05,"price_display":"172.05","price_state":"stated","total_value":154845.0,"total_display":"154,845.00","total_whole":"154,845","shares_owned_after":23714.0,"shares_owned_after_display":"23,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-14","scope":"insider"},{"id":8323604,"accession":"0001127602-19-034705","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001127602-19-034705","line_url":"/filing/0001127602-19-034705","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1051.0,"shares_display":"1,051","price_per_share":145.548715509039,"price_display":"145.55","price_state":"stated","total_value":152971.7,"total_display":"152,971.70","total_whole":"152,972","shares_owned_after":17925.0,"shares_owned_after_display":"17,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider","n_lines":14},{"id":8262542,"accession":"0001127602-19-034703","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-30","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":217.0,"shares_display":"217","price_per_share":145.11,"price_display":"145.11","price_state":"stated","total_value":31488.87,"total_display":"31,488.87","total_whole":"31,489","shares_owned_after":19121.0,"shares_owned_after_display":"19,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262535,"accession":"0001127602-19-034703","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-29","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194.0,"shares_display":"194","price_per_share":144.77,"price_display":"144.77","price_state":"stated","total_value":28085.38,"total_display":"28,085.38","total_whole":"28,085","shares_owned_after":20976.0,"shares_owned_after_display":"20,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262528,"accession":"0001127602-19-034703","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-28","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188.0,"shares_display":"188","price_per_share":145.16,"price_display":"145.16","price_state":"stated","total_value":27290.08,"total_display":"27,290.08","total_whole":"27,290","shares_owned_after":18933.0,"shares_owned_after_display":"18,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262525,"accession":"0001127602-19-034703","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-27","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178.0,"shares_display":"178","price_per_share":144.79,"price_display":"144.79","price_state":"stated","total_value":25772.62,"total_display":"25,772.62","total_whole":"25,773","shares_owned_after":20798.0,"shares_owned_after_display":"20,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262520,"accession":"0001127602-19-034703","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-26","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176.0,"shares_display":"176","price_per_share":144.87,"price_display":"144.87","price_state":"stated","total_value":25497.12,"total_display":"25,497.12","total_whole":"25,497","shares_owned_after":20260.0,"shares_owned_after_display":"20,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262516,"accession":"0001127602-19-034703","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-25","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":156.0,"shares_display":"156","price_per_share":145.06,"price_display":"145.06","price_state":"stated","total_value":22629.36,"total_display":"22,629.36","total_whole":"22,629","shares_owned_after":19510.0,"shares_owned_after_display":"19,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262512,"accession":"0001127602-19-034703","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-24","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149.0,"shares_display":"149","price_per_share":144.8,"price_display":"144.80","price_state":"stated","total_value":21575.2,"total_display":"21,575.20","total_whole":"21,575","shares_owned_after":20649.0,"shares_owned_after_display":"20,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262508,"accession":"0001127602-19-034703","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-23","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":145.095,"price_display":"145.10","price_state":"stated","total_value":19732.92,"total_display":"19,732.92","total_whole":"19,733","shares_owned_after":19338.0,"shares_owned_after_display":"19,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262504,"accession":"0001127602-19-034703","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-22","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124.0,"shares_display":"124","price_per_share":144.84,"price_display":"144.84","price_state":"stated","total_value":17960.16,"total_display":"17,960.16","total_whole":"17,960","shares_owned_after":20436.0,"shares_owned_after_display":"20,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262500,"accession":"0001127602-19-034703","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-21","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106.0,"shares_display":"106","price_per_share":144.92,"price_display":"144.92","price_state":"stated","total_value":15361.52,"total_display":"15,361.52","total_whole":"15,362","shares_owned_after":20039.0,"shares_owned_after_display":"20,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8262496,"accession":"0001127602-19-034703","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001127602-19-034703","line_url":"/filing/0001127602-19-034703#line-20","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001732091","owner_name":"Girshick Birgit","owner_display_name":"Girshick Birgit","owner_url":"/insider/0001732091","role":"Officer (Corporate Executive VP)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":145.05,"price_display":"145.05","price_state":"stated","total_value":14505.0,"total_display":"14,505.00","total_whole":"14,505","shares_owned_after":19666.0,"shares_owned_after_display":"19,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"}],"collapsed":true,"next_cursor":"2019-12-09|8262496","ledger_fault":false,"count":{"value":159,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":157,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":159},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001100682","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","url":"/issuer/0001100682","role":"Director, Officer (Chief Executive Officer)","n_filings":17,"first_seen":"2018-03-07","last_seen":"2026-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001732091","retrieved_at":"2026-08-22T09:46:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}